Can Wegovy treat depression as well as obesity?

The memory and focus problems common to depression, researchers hope, may be alleviated by GLP-1 drugs like Wegovy.

January 30, 2024 Check out STAT+

Sponsored By

ILLUSTRATION: CHRISTINE KAO/STAT; PHOTOS: ADOBE STAT+ | Can Wegovy treat depression as well as obesity? New research looks to GLP-1 drugs for mental illnesses Researchers are studying whether drugs like Ozempic and Wegovy can treat mental health diseases like depression and bipolar disorder. By Elaine Chen STAT+ | FDA's Woodcock reflects on more than 30 years at agency — and hints at what's next It's the end of an era for the Food and Drug Administration's longtime drug chief, Janet Woodcock. She talked about flexibility and the future with STAT. By Sarah Owermohle STAT+ | Vertex's closely watched pain relief drug succeeds in late-stage trials — with a catch The therapy performed well against placebo in Phase 3 trials, but didn't relieve pain better than a combination of acetaminophen and the opioid hydrocodone. By Jonathan Wosen Adobe STAT+ | Sophisticated phishing and deepfakes: How generative AI brings new threats for hospitals Security experts caution that health care systems are particularly at risk as hackers leverage generative AI to plan sophisticated attacks. By Mohana Ravindranath STAT+ | Ultima Genomics launching high-end DNA sequencers that can read genome for $100 The product from DNA sequencing company Ultima Genomics is roughly comparable to a line of high-throughput instruments from Illumina. By Jonathan Wosen STAT+ | Cour Pharmaceuticals, a biotech taking aim at autoimmune diseases, raises $105 million Cour Pharmaceuticals is developing a sort of Trojan horse that it hopes can be used to treat various autoimmune diseases. By Allison DeAngelis Photo by Scott Olson/Getty Images Opinion: The emergency room is where the United States' social problems come home to roost In this excerpt from her new book "Legacy," Uché Blackstock examines how health disparities play out in the ER. By Uché Blackstock The U.S. hasn't seen syphilis numbers this high since 1950. Other STD rates are down or flat Total syphilis cases surpassed 207,000 in 2022, the highest count in the United States since 1950, according to data released Tuesday. By Associated Press

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser